BSX vs GAP · P/E 20, rev $16.75B vs P/E 9.9, rev $15.09B
Boston Scientific Corp (BSX) versus The Gap, Inc. (GAP) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
The Gap, Inc. (GAP) is a apparel retail company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported GAP revenue for 2025-02-01 was $15.09B. Net income was $844.0M. Revenue was up 1.3% from 2024-02-03 to 2025-02-01. GAP currently screens at market cap $7.73B and trailing P/E 9.9.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. GAP currently screens at market cap $7.73B and trailing P/E 9.9.
Not investment advice. Open the BSX and GAP stock pages for the full models.
Not investment advice.